이홍기

교수
    

  #백혈병#악성림프종#다발성골수종#빈혈#혈전증#조혈모세포이식#EBS명의#헬스조선명의

학력

2003 | 연세대학교 의과대학원 졸업 (의학박사)
1982 | 연세대학교 의과대학 졸업 (의학사)

경력

2020-현재 | 대한병원협회 정보화추진위원회 부위원장
2020-현재 | 한국조혈모세포은행협회 부회장
2019-현재 | 건국대학교 의무부총장 겸 의료원장
2017-현재 | 건강보험분쟁조정위원회 위원
2017-현재 | 한국원자력의학원 방사선화상자문위원회 위원
2006-현재 | 건국대학교 의학전문대학원 내과학 교수; 건국대학교병원 종양혈액내과 교수
2006-현재 | 한국혈액암협회 이사 및 부회장
2019-2020 | 대한병원협회 상임이사
2016-2020 | 한국조혈모세포은행협회 감사
2015-2019 | 건국대학교병원 혈액암센터 센터장
2007-2019 | 건강보험심사평가원 진료심사평가위원회 비상근심사위원
2012-2016 | 한국조혈모세포은행협회 기증자보호위원회 위원장
2006-2016 | 건국대학교병원 종양혈액내과 과장
2010-2014 | 식품의약품안전청 중앙약사심의위원회 전문가
2008-2014 | 건국대학교 의학전문대학원 내과학교실 주임교수
2010-2012 | 건국대학교병원 임상시험센터 센터장
2007-2009 | 건국대학교병원 내과 과장
2007-2009 | 건국대학교병원 병원장
2004-2006 | East Carolina University The Brody School of Medicine (Greenville, North Carolina) 혈액종양내과 교수
2004-2006 | Pitt County Memorial Hospital (Greenville, NC, USA) 조혈모세포이식센터장
1997-2004 | 성균관대학교 의과대학 내과학 교수
1995-2004 | 삼성서울병원 혈액종양내과 전문의
2001-2002 | 한국조혈모세포은행협회 이식조정위원회 부위원장
1994-1995 | Roswell Park Cancer Institute (Buffalo, New York) 조혈모세포이식 전임의
1991-1994 | University of Cincinnati Medical Center (Cincinnati, Ohio) 혈액종양내과 전임의
1988-1991 | Cook County Hospital (Chicago, Illinois) 내과 레지던트
1985-1986 | 연세대학교 세브란스병원 인턴
1986-1988 | St. Francis Hospital (Evanston, IL, USA) 심장흉부외과 임상의

논문

Lee HK. Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone. International Journal of Hematology. 2021 Jan;113(1):81-91.

Kim SY, Lee HK. Treatment outcome and prognostic factors of Korean patients with chronic lymphocytic leukemia: a multicenter retrospective study. Korean Journal of Internal Medicine. 2021 Jan;36(1):194-204.

Lee HK. Treatment with Intravenous Busulfan, Melphalan, and Etoposide (BuME) followed by Autologous Stem Cell Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from the Consortium for Improving Survival of Lymphoma (CISL). Transplant International. 2020 Oct;33(10):1211-9.

Lee HK. Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia. Journal of Clinical Medicine. 2020 Jul;9(7):2310.

Hong DY, Lee HK. The Inhibitory Mechanisms of Tumor PD-L1 Expression by Natural Bioactive Gallic Acid in Non-Small-Cell Lung Cancer (NSCLC) Cells. Cancers. 2020 Mar;12(3):727.

Kim H, Moon HW, Yun YM, Lee HK, Hur M. A case of reactive erythrocytosis with CD34/CD61 dual positive megakaryocytes. International Journal of Laboratory Hematology. 2020 Feb;42(1):e17-9.

Lee HK. The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study). Annals of Hematology. 2020 Feb;99(2):309-19.

Yoon S, Kim H, Hur M, Han SH, Chung HJ, Moon HW, Yun YM, Lee MH. Do we still need morphologic evaluation in new era of advanced minimal residual disease analyses?. International Journal of Laboratory Hematology. 2019 Dec;41(6):e145-e147.

Park M, Hur M, Yi A, Kim H, Lee HK, Jeon EY, Oh KM, Lee MH. Utility of temperature-sensitive indicators for temperature monitoring of red-blood-cell units. Vox Sanguinis. 2019 Jul;114(5):487-494.

Jung SH, Lee SR, Yang DH, Lee S, Yoon JH, Lee H, Bang SM, Koh Y, Park S, Kim DS, Yhim HY, Kim SH, Lee JH, Sohn SK, Song IC, Lee HG, Cheong JW, Choi Y, Shin HJ. Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party. Annals of Hematology. 2019 Jan;98(1):151-158.

Cheong HS, Ki HK, Kim SY, Kim JY, Lee HG. Oral mucormycosis in patients with haematologic malignancies in a bone marrow transplant unit. Mycoses. 2017 Dec;60(12):836-41.

Lee HK. Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS working party. Oncotarget. 2017 Oct 3;8(45):79414-24.

Lee HK. A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma. Oncotarget. 2017 Jun 6;8(23):37605-18.

Cho SH, Suh C, Do YR, Lee JJ, Yun HJ, Oh SY, Lee HS, Cho SG, Cho IS, Lee WS, Won YW, Kim HJ, Lee HG, Lee SI, Lim SN, Sohn BS, Ahn HJ, Chang MH, Kwon KA, Kim WS. Clinical features and survival of patients with follicular lymphoma in Korea. Clin Lymphoma, Myeloma, Leukemia. 2016.

Ahn JS, Kim YK, Min YH, Cheong JW, Jang JH, Jung CW, Kim IH, Yoon HJ, Lee HG, Sohn SK, Moon JH, Kim H, Kim YJ, Won JH, Chung JS, Mun YC, Lee JH, Kim HJ. Azacitidine pre-treatment followed by reduced-intensity stem cell transplantation in patients with higher-risk myelodysplastic syndrome. Acta Haematologica. 2015;134:40-48.

Kim HJ, Hur M, Kim H, Moon HW, Yun YM, Kim SY, Lee MH. A rare case of Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma with light chain discrepancy between B lymphocyte population and serum paraprotein. Ann Clin Lab Sci. 2015;45:593-597.

Kim SY, Kim AR, Yoon SY, Cho YH, Lee MH. Substitution of methotrexate with corticosteroids for acute graft-versus-host disease prevention in transplanted patients who develop methotrexate toxicity. Ann Hematol. 2015;95:483-491.

Park SY, Yu HM, Kim J, An SH, Kim WY, Hur M, Lee HG. Hodgkin’s lymphoma after autologous hematopoietic stem cell transplantation for angioimmunoblastic T-cell lymphoma. Korean J Med. 2014;86:774-780.

Lee HG, Choi YS, Kim SY, Kim IH, Kim YK, Kim YS, Lee HS, Kim SJ, Kim JA, Park BB, Park J, Shim H, Eom HS, Lee JL, Park SK, Cheong JW, Park KW. R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma. Blood Research. 2014;49:107-14.

Yoon SY, Kim JH, Kim WS, Chung HW, Lee MH, Kim SY, Cho YH. Pleural metastasis as initial presentation of occult gastric cardia cancer: a possible role of PET-CT in diagnosis. Cancer Res Treat. 2014;46:415-418.

Kim SW, Yu HM, Lee YJ, Kim HJ, Hur M, Lee HG. Polycythemia vera presenting with generalized chorea: a case report and review of the literature. Korean J Med. 2014;87:619-624.

Kim SJ, Kang WC, Kim SW, Lee YJ, Kim WY, Kim HJ, Lee HG. Metastatic pulmonary calcification in a patient with adult T-cell leukemia/lymphoma. Korean J Med. 2014;87:750-755.

Lee HS, Kim K, Yoon DH, Kim JS, Bang SM, Lee JO, Eom HS, Lee H, Kim I, Lee WS, Bae SH, Kim SH, Lee MH, Do YR, Lee JH, Hong JS, Shin HJ, Lee JH, Mun YC, Min CK. Clinical factors associated with response of survival after chemotherapy in patients with Waldenstrom Macroglobulinemia in Korea. BioMed Research International. 2014.

Park SY, Yu HM, Kim J, An SH, Kim WY, Hur M, Lee HG. Hodgkin’s lymphoma after autologous hematopoietic stem cell transplantation for angioimmunoblastic T-cell lymphoma. Korean J Med. 2014;86:774-780.

Lee HG, Choi YS, Kim SY, Kim IH, Kim YK, Kim YS, Lee HS, Kim SJ, Kim JA, Park BB, Park J, Shim H, Eom HS, Lee JL, Park SK, Cheong JW, Park KW. R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma. Blood Research. 2014;49:107-14.

Yoon SY, Kim JH, Kim WS, Chung HW, Lee MH, Kim SY, Cho YH. Pleural metastasis as initial presentation of occult gastric cardia cancer: a possible role of PET-CT in diagnosis. Cancer Res Treat. 2014;46:415-418.

Kim SW, Yu HM, Lee YJ, Kim HJ, Hur M, Lee HG. Polycythemia vera presenting with generalized chorea: a case report and review of the literature. Korean J Med. 2014;87:619-624.

Kim SJ, Kang WC, Kim SW, Lee YJ, Kim WY, Kim HJ, Lee HG. Metastatic pulmonary calcification in a patient with adult T-cell leukemia/lymphoma. Korean J Med. 2014;87:750-755.

Lee YG, Kim I, Yoon SS, Park S, Cheong JW, Min YH, Lee JO, Bang SM, Yi HG, Kim CS, Park Y, Kim BS, Mun YC, Seong CM, Lee JH, Kim SY, Lee HG, Kim YK, Kim HJ. Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes. Br J Haematol. 2013;161:339-347.

Kim K, An S, Cha HJ, Choi YM, Choi SJ, An IS, Lee HG, Min YH, Lee SJ, Bae S. Lenalidomide induces apoptosis and alters gene expression in non-small cell lung cancer cells. Oncol Lett. 2013;5:588-592.

저서

임상심장학

혈액학

보도자료

[암과의 동행-암과 영양] 이홍기 건국대병원 혈액종양내과 교수 “무조건 기름진 음식 기피는 곤란”
http://news.kmib.co.kr/article/view.asp?arcid=0923279626&code=14130000&cp=nv

[센터 탐방] 건국대병원 혈액암센터, 진료-관련부서 연계로 환자 치유 지원
http://www.kukinews.com/newsView/kuk201612040080

가임기 여성과 임산부에게 쉽게 생길 수 있는 빈혈…증상은?
http://www.mdtoday.co.kr/mdtoday/index.html?no=292921

이홍기 교수, "조혈모세포 기증한 女에 고마워..굉장히 숭고한 것"
https://cnews.thekpm.com/view.php?ud=20190222233041323192b25ecb1b_17

[건강한 가족] 의료진·지원인력 '원팀' 이뤄 혈액암 환자에게 희망 전파
https://news.joins.com/article/24037820

포스팅

포스팅 내용이 없습니다.

영상자료

[EBS 명의] 혈액암, 나는 안전한가
https://bestdoctors.ebs.co.kr/bestdoctors/vodReplayView;jsessionid=2aa8oAINcXKUsIGs8DWNDYJqSUpu5tgzSgpfyxhnmbJlfjhMJraQeYMavr7aTlxC.enswasp03_servlet_engine2?siteCd=ME&prodId=454&courseId=&stepId=&lectId=20045175

[건국대학교병원 현장 LIVE] #3 ‘네 가지 백혈병 바로 알기’ (건국대학교 의료원장 이홍기 교수 & 차종은 PD)
https://youtu.be/TSgSgGh0LEg

발표자료

발표자료 내용이 없습니다.